Would-be cancer centers want to treat patients with Right to Try drugs
A private equity firm is soliciting investors to create a chain of cancer centers focused on providing experimental medicines under the Right to Try law.
A private equity firm is soliciting investors to create a chain of cancer centers focused on providing experimental medicines under the Right to Try law.
Trump has pledged to stop federal funding of gender-affirming care and to expel from Medicare and Medicaid any hospitals that provide it to minors
Peter McCullough, Casey Means, Joel Salatin, and Simone Gold are all getting upvotes on a MAHA nomination site for the Trump administration.
STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.
A new study found that a small but not insignificant number of bird flu infections are going undetected among farm workers
The company believes Chinese authorities are probing allegations that two current and two former employees had illegally imported cancer drugs.
GSK is the fifth biopharma firm to depart BIO in roughly a year.
A Baird analyst and longtime biotech executive speak with Readout LOUD hosts about how a Trump presidency could affect the FDA and the biotech industry.
Join STAT for a LinkedIn Live conversation featuring chief Washington correspondent Rachel Cohrs Zhang, biotech startups and venture capital reporter, Allison DeAngelis, and general assignment…
Trump has pledged to stop federal funding of gender-affirming care and to expel from Medicare and Medicaid any hospitals that provide it to minors
Peter McCullough, Casey Means, Joel Salatin, and Simone Gold are all getting upvotes on a MAHA nomination site for the Trump administration.